Cambridge Investment Research Advisors, Inc. Fulgent Genetics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$23.64 - $30.27 $34,088 - $43,649	-1,442 Reduced 13.64%	9,130 $264,000
Q3 2023 Oct 24, 2023	BUY	$26.74 - $40.81 $18,530 - $28,281	693 Added 7.01%	10,572 $283,000
Q2 2023 Jul 13, 2023	SELL	$28.52 - $40.7 $12,006 - $17,134	-421 Reduced 4.09%	9,879 $366,000
Q1 2023 May 11, 2023	BUY	$29.39 - $36.27 $12,549 - $15,487	427 Added 4.32%	10,300 $322,000
Q4 2022 Feb 08, 2023	SELL	$29.23 - $40.28 $55,975 - $77,136	-1,915 Reduced 16.25%	9,873 $294,000
Q3 2022 Oct 17, 2022	BUY	$37.92 - $63.74 $45,011 - $75,659	1,187 Added 11.2%	11,788 $449,000
Q2 2022 Jul 13, 2022	BUY	$47.98 - $62.75 $7,244 - $9,475	151 Added 1.44%	10,601 $578,000
Q1 2022 May 12, 2022	SELL	$49.85 - $96.11 $697 - $1,345	-14 Reduced 0.13%	10,450 $652,000
Q4 2021 Feb 03, 2022	BUY	$77.3 - $105.0 $349,473 - $474,705	4,521 Added 76.07%	10,464 $1.05 Million
Q3 2021 Nov 02, 2021	SELL	$74.87 - $110.87 $101,673 - $150,561	-1,358 Reduced 18.6%	5,943 $534,000
Q2 2021 Aug 10, 2021	BUY	$66.8 - $100.45 $86,639 - $130,283	1,297 Added 21.6%	7,301 $673,000
Q1 2021 May 07, 2021	BUY	$59.3 - $183.85 $356,037 - $1.1 Million	6,004 New	6,004 $580,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

Black Rock Inc. New York, NY

3.92M
Shares

$78.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.45M
Shares

$29.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.27M
Shares

$25.6 Million
0.01% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.11M
Shares

$22.3 Million
0.01% of portfolio
State Street Corp Boston, MA

794K
Shares

$16 Million
0.0% of portfolio

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account